Therapeutic Advances in Respiratory Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 60.7% | 1.009 | Q1 | 84.1% |
| 2024 | 3.0 | Q2 | 67.6% | 0.970 | Q1 | 83.4% |
| 2023 | 3.3 | Q2 | 69.9% | 1.179 | Q1 | 89.0% |
| 2022 | 4.3 | Q2 | 77.4% | 1.092 | Q1 | 88.1% |
| 2021 | 5.2 | Q2 | 81.1% | 1.219 | Q1 | 90.2% |
| 2020 | — | — | 1.022 | Q2 | 85.7% | |
| 2019 | — | — | 0.913 | Q2 | 83.6% | |
| 2018 | — | — | 1.020 | Q2 | 84.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1753-4666
ISSN
1753-4658
country
GBcoverage
2007-2026